ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
1-Year Return
11.37%
This Quarter Return
-17.28%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$2.96B
AUM Growth
-$441M
(-13%)
Cap. Flow
+$439M
Cap. Flow
% of AUM
14.82%
Top 10 Holdings %
Top 10 Hldgs %
65.67%
Holding
42
New
12
Increased
9
Reduced
9
Closed
–
Top Buys
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
+$77.3M |
| 2 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
+$61.8M |
| 3 |
PTC Therapeutics
PTCT
|
+$53.5M |
| 4 |
Relmada Therapeutics
RLMD
|
+$39.2M |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$34.7M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
+$17.1M |
| 2 |
Ascendis Pharma
ASND
|
+$8.78M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
+$5.92M |
| 4 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$4.92M |
| 5 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
+$4.29M |
Sector Composition
| 1 | Healthcare | 87.74% |
